Last reviewed · How we verify

NCT05974800: OVERSEE-II

Potential Improvements in Emergency Department Care for Cancer Patients According to Clinical Staff

Completed Last updated 15 October 2024
What this trial tests

trial testing Emergency department caregivers interview in Cancer in 59 participants. Completed in 1 October 2024.

Timeline
2 February 2024
Primary endpoint
1 September 2024
1 October 2024

Quick facts

Lead sponsorErasmus Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment59
Start date2 February 2024
Primary completion1 September 2024
Estimated completion1 October 2024
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Erasmus Medical Center

Who can join

18 and older, any sex, with Cancer or Emergencies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this Single center prospective cross-sectional study is to identify the facilitators and barriers among caregivers in the emergency department that influence disposition of patients with solid and hematology malignancies. The main question it aims to answer is to categorize the facilitators and barriers identified by three groups of emergency department (ED) staff. Participants will be asked for permission, afterwards a short interview will be held with the different ED caregivers (ED nurse, attending physician and supervising physician).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Erasmus Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05974800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing